TABLE 1—
Variable | Total, No. (%), Mean ±SD, or Median (Q1, Q3) | African American, Total, No. (%), Mean ±SD, or Median (Q1, Q3) | White, Total, No. (%), Mean ±SD, or Median (Q1, Q3) | Other, Total, No. (%), Mean ±SD, or Median (Q1, Q3) | P |
Total | 801 (100.0) | 601 (75.0) | 127 (15.9) | 73 (9.1) | |
Comorbiditya | |||||
Yes | 68 (8.5) | 54 (9.0) | 6 (4.7) | 8 (11.0) | .21 |
No | 733 (91.5) | 547 (91.0) | 121 (95.3) | 65 (89.0) | |
Gendera | |||||
Female | 361 (45.1) | 279 (46.4) | 48 (37.8) | 34 (46.6) | .19 |
Male | 440 (54.9) | 322 (53.6) | 79 (62.2) | 39 (53.5) | |
Residential statusa | |||||
Urban | 667 (83.3) | 513 (85.4) | 102 (80.3) | 52 (71.2) | < .01 |
Rural | 134 (16.7) | 88 (14.6) | 25 (19.7) | 21 (28.8) | |
Age,b y | 54.5 ±3.7 | 54.6 ±3.7 | 54.2 ±3.6 | 54.4 ±3.9 | .52 |
Timely ART initiationa | |||||
Yes, ≤ 90 d | 397 (49.6) | 289 (48.1) | 64 (50.4) | 44 (60.3) | .18 |
No, > 90 d | 404 (50.4) | 312 (51.9) | 63 (49.6) | 29 (39.7) | |
Time to ART initiation,c d | 96 (13, 365) | 114 (13, 365) | 66 (15, 365) | 28 (7, 365) | .16 |
Note. ART = antiretroviral therapy; Q = quartile.
χ2 test.
Analysis of variance.
Kruskal–Wallis test.